Rituximab for connective tissue disease associated with interstitial lung disease

Document first published:
Page updated:
Topic:
,
Publication type:

This policy document outlines the arrangements for funding of this treatment for the population in England.

Document

Rituximab for connective tissue disease associated with interstitial lung disease

Rituximab for connective tissue disease associated with interstitial lung disease

  • PDF
  • 360 KB
  • 14 pages

Summary

In creating this policy NHS England has reviewed this clinical condition and the options for its treatment. It has considered the place of this treatment in current clinical practice.